Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +21.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (419)

clinicaltrialsPublishedShowing 2,851–2,864 of 2,864 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00180791	High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood	unknown	Phase 2	71	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Sep 18, 2007	clinicaltrials
NCT00521482	Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma	unknown	Phase 2	40	University of ZurichOTHER	1	Aug 28, 2007	clinicaltrials